Suspicions have been raised that Johnson & Johnson's Covid-19 vaccine has the same possible side effects as Astrazeneca's vaccine.
For this reason, the European Medicines Agency (EMA) will be investigating Johnson & Johnson's vaccine further, according to Head of Unit Tanja Erichsen at the Danish Medicines Agency (DMA).
More from MedWatch
In 2015, Genmab partnered with relatively unknown biotech firm Biontech. Reflecting on how far Genmab has come since, CEO Jan van de Winkel is still confident that partnerships, rather than acquisitions, are the way forward. If it had acquired Biontech at the time, the CEO speculates Genmab may have put a stop to other activities – including the Covid-19 vaccine efforts that went on to save millions of lives. This and fairness are worth remembering as biotech firms are increasingly strapped for cash, van de Winkel reflects.